MAWDBP Antibody (1): sc-101502
- MAWDBP Antibody (1) is a mouse monoclonal IgG1 κ MAWDBP antibody, cited in 2 publications, provided at 200 µg/ml
- raised against recombinant MAWDBP of human origin
- MAWDBP Antibody (1) is recommended for detection of MAWDBP of human and, to a lesser extent, mouse, rat origin by WB and IP
- Anti-MAWDBP Antibody (1) is available conjugated to agarose for IP; HRP for WB, IHC(P) and ELISA; and to either phycoerythrin or FITC for IF, IHC(P) and FCM
- also available conjugated to Alexa Fluor® 488, Alexa Fluor® 546, Alexa Fluor® 594 or Alexa Fluor® 647 for WB (RGB), IF, IHC(P) and FCM, and for use with RGB fluorescent imaging systems, such as iBright™ FL1000, FluorChem™, Typhoon, Azure and other comparable systems
- also available conjugated to Alexa Fluor® 680 or Alexa Fluor® 790 for WB (NIR), IF and FCM; for use with Near-Infrared (NIR) detection systems, such as LI-COR®Odyssey®, iBright™ FL1000, FluorChem™, Typhoon, Azure and other comparable systems
- At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for MAWDBP Antibody (1). This work is in progress.
QUICK LINKS
SEE ALSO...
MAWDBP Antibody (1) is a mouse monoclonal IgG1 kappa light chain antibody that detects MAWDBP protein of human origin, and to a lesser extent, mouse and rat origins, by western blotting (WB) and immunoprecipitation (IP). Anti-MAWDBP antibody (1) is available in both non-conjugated and various conjugated forms, including agarose, horseradish peroxidase (HRP), phycoerythrin (PE), fluorescein isothiocyanate (FITC), and multiple Alexa Fluor® conjugates. MAWDBP protein, also known as PBLD (phenazine biosynthesis-like protein domain containing) or MAWBP, consists of 288 amino acids and is a member of the phenazine biosynthesis-like protein (PhzF) family, which is believed to be uniquely represented in the human genome. MAWDBP protein is predominantly expressed in various tissues and functions as a WD-40 repeat-containing β-propeller protein, playing a crucial role in the MAPK signaling pathway. MAWDBP expression levels are elevated in conditions such as insulin resistance, folate deficiency, and hypotension, suggesting involvement in these disease states. MAWDBP protein is also implicated in carcinogenesis, highlighting significance in cancer research.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
MAWDBP Antibody (1) References:
- The purification, crystallization and preliminary structural characterization of PhzF, a key enzyme in the phenazine-biosynthesis pathway from Pseudomonas fluorescens 2-79. | Mavrodi, DV., et al. 2004. Acta Crystallogr D Biol Crystallogr. 60: 184-6. PMID: 14684924
- Structure and function of the phenazine biosynthesis protein PhzF from Pseudomonas fluorescens 2-79. | Parsons, JF., et al. 2004. Biochemistry. 43: 12427-35. PMID: 15449932
- Structure of the phenazine biosynthesis enzyme PhzG. | Parsons, JF., et al. 2004. Acta Crystallogr D Biol Crystallogr. 60: 2110-3. PMID: 15502343
- Structure and function of the phenazine biosynthetic protein PhzF from Pseudomonas fluorescens. | Blankenfeldt, W., et al. 2004. Proc Natl Acad Sci U S A. 101: 16431-6. PMID: 15545603
- Proteome of H-411E (liver) cells exposed to insulin and tumor necrosis factor-alpha: analysis of proteins involved in insulin resistance. | Solomon, SS., et al. 2005. J Lab Clin Med. 145: 275-83. PMID: 15902099
- Crystal structure of YHI9, the yeast member of the phenazine biosynthesis PhzF enzyme superfamily. | Liger, D., et al. 2005. Proteins. 60: 778-86. PMID: 16021630
- Proteomic analysis reveals changes in the liver protein pattern of rats exposed to dietary folate deficiency. | Chanson, A., et al. 2005. J Nutr. 135: 2524-9. PMID: 16251605
- The purification, crystallization and preliminary structural characterization of human MAWDBP, a member of the phenazine biosynthesis-like protein family. | Herde, P. and Blankenfeldt, W. 2006. Acta Crystallogr Sect F Struct Biol Cryst Commun. 62: 546-9. PMID: 16754977
- Proteomic and transcriptomic analysis for streptozotocin-induced diabetic rat pancreas in response to fungal polysaccharide treatments. | Kim, SW., et al. 2008. Proteomics. 8: 2344-61. PMID: 18452227
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MAWDBP Antibody (1) | sc-101502 | 200 µg/ml | $322.00 | |||
MAWDBP Antibody (1) AC | sc-101502 AC | 500 µg/ml, 25% agarose | $424.00 | |||
MAWDBP Antibody (1) HRP | sc-101502 HRP | 200 µg/ml | $322.00 | |||
MAWDBP Antibody (1) FITC | sc-101502 FITC | 200 µg/ml | $336.00 | |||
MAWDBP Antibody (1) PE | sc-101502 PE | 200 µg/ml | $349.00 | |||
MAWDBP Antibody (1) Alexa Fluor® 488 | sc-101502 AF488 | 200 µg/ml | $364.00 | |||
MAWDBP Antibody (1) Alexa Fluor® 546 | sc-101502 AF546 | 200 µg/ml | $364.00 | |||
MAWDBP Antibody (1) Alexa Fluor® 594 | sc-101502 AF594 | 200 µg/ml | $364.00 | |||
MAWDBP Antibody (1) Alexa Fluor® 647 | sc-101502 AF647 | 200 µg/ml | $364.00 | |||
MAWDBP Antibody (1) Alexa Fluor® 680 | sc-101502 AF680 | 200 µg/ml | $364.00 | |||
MAWDBP Antibody (1) Alexa Fluor® 790 | sc-101502 AF790 | 200 µg/ml | $364.00 |